Results 41 to 50 of about 70,554 (240)

PERBEDAAN ANGKA KEJADIAN BENIGN PROSTATIC HYPERPLASIA PADA USIA ANTARA 50-59 TAHUN DENGAN USIA DIATAS 60 TAHUN PADA PEMERIKSAAN ULTRASONOGRAFI DI RS. PKU (PEMBINA KESEJAHTERAAN UMAT) MUHAMMADIYAH SURAKARTA [PDF]

open access: yes, 2010
Farida kumala sari 2010. Perbedaan angka kejadian benign prostatic hyperplasia pada usia antara 50-59 tahun dengan usia diatas 60 tahun pada pemeriksaan ultrasonografi di RS. PKU (Pembina Kesejahteraan Umat) Muhammadiyah Surakarta.
SARI, FARIDA KUMALA
core  

Dynamic Shifts in ER–Plasma Membrane Junctions Signaling Define Pro‐Metastatic N‐Glycosylation and Predict Prostate Cancer Progression

open access: yesAdvanced Science, EarlyView.
Prostate cancer remains a leading cause of male cancer death, yet screening cannot reliably identify aggressive disease, underscoring the need for tissue biomarkers. It is shown that primary tumors increase ER–plasma membrane junction signaling via STIM1/ORP5, whereas metastasis features their loss, Golgi dispersal, and rapid conversion of high‐mannose
Amanda J. Macke   +14 more
wiley   +1 more source

PERBEDAAN BAKTERIURIA PADA PASIEN BENIGN PROSTATIC HYPERPLASIA DENGAN VOLUME PROSTAT TINGGI DAN TIDAK TINGGI [PDF]

open access: yes, 2016
Multazam Hanif, G0012141, 2016. Perbedaan Bakteriuria Pada Pasien Benign Prostatic Hyperplasia dengan Volume Prostat Tinggi dan Tidak Tinggi. Skripsi. Fakultas Kedokteran, Universitas Sebelas Maret, Surakarta.
Hanif, Multazam
core  

Large‐Scale Quantitative Morphometry of Platelet α‐Granules via SIM Super‐Resolution Microscopy for Cancer Liquid Biopsy

open access: yesAdvanced Science, EarlyView.
ABSTRACT Blood‐based liquid biopsies hold transformative potential for non‐invasive cancer management, but current approaches relying on rare circulating tumor components limit their broad clinical utility. Platelets, abundant in blood and mediating diverse cancer‐associated responses, represent a compelling yet largely unexplored alternative.
Yan Ma   +28 more
wiley   +1 more source

The Contribution of Prostatic Acid Phosphatase and Prostatic Specific Antigen in the Diagnosis of Prostatic Cancer

open access: yesThe International Journal of Biological Markers, 1988
Prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) were measured by immunochemical methods using test preparations from two different companies.
A. van Dalen   +2 more
doaj   +1 more source

HUBUNGAN SINDROM METABOLIK DENGAN BENIGN PROSTATIC HYPERPLASIA (BPH) DI RSUDZA BANDA ACEH [PDF]

open access: yes, 2017
ABSTRAKSalah satu penyebab Benign Prostatic Hyperplasia (BPH) diduga Sindrom Metabolik (SM). Parameter SM pada penelitian ini berdasarkan konsensus internasional dari International Diabetes Federation (IDF). Tujuan penelitian ini adalah untuk mengetahui
ADE BETRIS AMIGIA
core  

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale   +5 more
wiley   +1 more source

Histopathological study of Prostatic Lesions in a Tertiary Care Hospital, Lahore [PDF]

open access: yesJournal of Sharif Medical & Dental College, 2021
Objective: To determine the spectrum of pathological lesions seen in prostatic biopsies & to grade prostatic cancers according to the modified Gleason score & grade.
Madiha Arshad   +2 more
doaj  

Silodosin oral films: Development, physico-mechanical properties and in vitro dissolution studies in simulated saliva [PDF]

open access: yes, 2019
Sublingual film dosage forms for drugs used for fast symptomatic treatment have promise because they allow a rapid onset of action. The aim of this study was to prepare films of silodosin intended for sublingual administration for the symptomatic ...
Adair   +57 more
core   +2 more sources

Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy